Search for:
Avacta Therapeutics
About
Our Science
Pipeline
News
Investors
Careers
Contact
About
About Avacta
Leadership
Scientific Resources
Intellectual Property
Our Science
Our Science
1st Gen
2nd Gen
3rd Gen
Partners
Clinical trials
Pipeline
News
Investors
Investors
Key info
Corporate Governance
Resources
Share price
RNS News
Events
Research
Careers
Job vacancies
Benefits of working at Avacta
Contact
About
About Avacta
Leadership
Scientific Resources
Intellectual Property
Our Science
Our Science
1st Gen
2nd Gen
3rd Gen
Partners
Clinical trials
Pipeline
News
Investors
Investors
Key info
Corporate Governance
Resources
Share price
RNS News
Events
Research
Careers
Job vacancies
Benefits of working at Avacta
Contact
Home
News
filter by:
view all
|
Blogs
|
Diagnostics
|
Investors
|
Podcasts and Videos
|
R&D Spotlights Series
|
Therapeutics
News
30 Jun 2025
Appointment of Zeus Capital as Joint Broker to Avacta Group plc
Investors
19 Jun 2025
New Response in the FAP-Dox (AVA6000) Phase 1b Trial
Investors
|
Therapeutics
09 Jun 2025
Posting of Annual Report and Revised Notice of AGM
Investors
06 Jun 2025
Preliminary Results for the Year Ended December 31, 2024
Investors
04 Jun 2025
Update on timing of preliminary results announcement
Investors
28 May 2025
Board appointments
Investors
27 May 2025
Update on timing of preliminary results announcement
Investors
15 May 2025
Notice of Results
Investors
12 May 2025
Investor Webinar
Investors
29 Apr 2025
Board change
Investors
Posts navigation
Older posts
Newer posts
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok